Please use this identifier to cite or link to this item:
Title: Expression and clinical significance of Wnt players and Survivin pituitary tumours
Authors: Formosa, Robert
Gruppetta, Mark
Falzon, Sharon
Santillo, Graziella
DeGaetano, James
Xuereb-Anastasi, Angela
Vassallo, Josanne
Keywords: Pituitary gland -- Tumors
Wnt proteins
Tumor proteins
Issue Date: 2012
Publisher: Springer Science+Business Media
Citation: Endocrine Pathology. 2012, Vol.23, p. 123-131
Abstract: Deregulation of the Wnt pathway has been implicated in oncogenesis of numerous tissues including the pituitary gland. Immunohistochemical localization and quantification of β-catenin, Cyclin D1, c-MYC and Survivin expression in 47 pituitary adenomas (35 non-functioning, seven GH-secreting, three prolactinomas, two CTHsecreting tumour) and six normal controls was undertaken in this study and correlation of protein expression to patient and tumour characteristics analysed. β-catenin was strictly membrane-bound with no difference observed between normal and tumour tissue. In contrast, Cyclin D1 and c-MYC localization was nuclear and significantly higher in tumour versus normal tissue (p<0.05). c-MYC expression correlated negatively with age at diagnosis (p00.006, R0−0.395) while Cyclin D1 expression correlated positively with age (p00.036, R00.306) and was higher in males than in females (p00.036). c-MYC expression was significantly lower in patients with functional tumours requiring octreotide treatment and in patients with non-functioning tumours suffering from hypopituitarism. Survivin expression was extremely low in tumours and absent in normal controls. Involvement of the canonical Wnt pathway appears to be minimal, given the segregation of β-catenin to the membrane. Our data suggest that c-MYC may have an important role in early pituitary tumorigenesis while Cyclin D1 is likely to promote tumour growth at a later stage. We also report a novel gender difference in Cyclin D1 expression, the biological significance of which merits further analysis. The reported reduction of c-MYC in functional tumours subsequently treated with octreotide further supports a role of c-MYC in early tumorigenesis and not in recurrence. The decrease in c-MYC in patients with hypopituitarism provides the first in vivo evidence for hormonal regulation of c-MYC expression.
Appears in Collections:Scholarly Works - FacHScABS
Scholarly Works - FacM&SMed
Scholarly Works - FacM&SPat

Files in This Item:
File Description SizeFormat 
Angela Xuereb - Expression and Clinical Significance of Wnt Players.pdf
  Restricted Access
366.38 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.